Versant Ventures

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, focused on enhancing respiratory rhythm management and cardiovascular health for heart failure patients. Founded in 2006, the company develops and manufactures innovative implantable stimulation therapy solutions, notably the remede System. This device is designed to restore normal breathing patterns during sleep for individuals suffering from central sleep apnea. Respicardia aims to improve the lives of these patients through safe and effective neurostimulation therapies that stimulate the phrenic nerve, thereby addressing critical needs in respiratory and cardiovascular health.

Monteris Medical, Inc. is a medical device company specializing in the development and marketing of innovative technologies for the treatment of brain diseases. Founded in 1999 and based in Plymouth, Minnesota, with additional offices in Minneapolis and Winnipeg, the company focuses on minimally-invasive, MRI-guided, and robotically controlled neurosurgical procedures. Its flagship product, the NeuroBlate System, utilizes focused laser energy to safely ablate pathological brain lesions, such as tumors, while minimizing damage to surrounding healthy tissue. Monteris Medical also provides various stereotactic anchoring devices and stabilization systems for enhanced precision during image-guided procedures. The company markets its products directly to neurosurgeons in the United States, aiming to improve surgical outcomes through advanced technology.

Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive products aimed at addressing underserved conditions of the lumbar spine. Founded in 2008 and headquartered in Minnetonka, Minnesota, the company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion in patients with conditions such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device intended to treat chronic facetogenic pain. The company is supported by a team of experienced engineers, marketing personnel, and management dedicated to advancing medical devices in the spine industry. Zyga Technology operates as a subsidiary of RTI Surgical, Inc.

RedBrick Health is a health technology company based in Minneapolis, founded in 2006 to address the challenges posed by rising healthcare costs. The company offers an innovative approach that combines behavior-based health financing with personalized programs and independent advocacy. RedBrick Health's enterprise platform leverages advanced behavior design and data analytics to promote healthier behaviors and facilitate informed healthcare decisions among consumers. By partnering with employers, health plans, health systems, and accountable care organizations, RedBrick Health aims to enhance population health and well-being initiatives, ultimately delivering improved health outcomes and financial rewards for its clients.

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

RedBrick Health is a health technology company based in Minneapolis, founded in 2006 to address the challenges posed by rising healthcare costs. The company offers an innovative approach that combines behavior-based health financing with personalized programs and independent advocacy. RedBrick Health's enterprise platform leverages advanced behavior design and data analytics to promote healthier behaviors and facilitate informed healthcare decisions among consumers. By partnering with employers, health plans, health systems, and accountable care organizations, RedBrick Health aims to enhance population health and well-being initiatives, ultimately delivering improved health outcomes and financial rewards for its clients.

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Zyga Technology, Inc. is a medical device company focused on the research, design, development, and commercialization of minimally invasive products aimed at addressing underserved conditions of the lumbar spine. Founded in 2008 and headquartered in Minnetonka, Minnesota, the company offers the SImmetry Sacroiliac Joint Fusion System, which provides a surgical solution for sacroiliac joint fusion in patients with conditions such as sacroiliac joint disruptions and degenerative sacroiliitis. Additionally, Zyga is developing the Glyder Facet Restoration System, an investigational device intended to treat chronic facetogenic pain. The company is supported by a team of experienced engineers, marketing personnel, and management dedicated to advancing medical devices in the spine industry. Zyga Technology operates as a subsidiary of RTI Surgical, Inc.

Hicuity Health is a technology-enabled clinical services provider specializing in high-acuity telehealth. It contracts to deliver care to more than 115 hospitals across 30 states on a 24/7/365 basis. The company combines remote patient monitoring, virtual care services, real-time clinical data integration, and access to specialized medical teams to support critical care delivery. It operates dedicated tele-care delivery centers and employs U.S. board-certified intensivists to support hospitals, families, and patients with improved oversight and care coordination, enabling scalable, around-the-clock critical care support for health systems.

RedBrick Health is a health technology company based in Minneapolis, founded in 2006 to address the challenges posed by rising healthcare costs. The company offers an innovative approach that combines behavior-based health financing with personalized programs and independent advocacy. RedBrick Health's enterprise platform leverages advanced behavior design and data analytics to promote healthier behaviors and facilitate informed healthcare decisions among consumers. By partnering with employers, health plans, health systems, and accountable care organizations, RedBrick Health aims to enhance population health and well-being initiatives, ultimately delivering improved health outcomes and financial rewards for its clients.

Nuvaira, Inc. is a medical device company based in Minneapolis, Minnesota, focused on developing innovative treatments for obstructive lung diseases, particularly chronic obstructive pulmonary disease (COPD). Founded in 2008, Nuvaira specializes in a novel catheter-based Lung Denervation System that aims to address airway nerve hyperactivity by targeting the parasympathetic innervation of the lungs. This minimally invasive procedure is designed to improve lung function, enhance exercise capacity, and elevate the quality of life for patients suffering from chronic respiratory conditions. With a commitment to advancing treatment options, Nuvaira seeks to reduce the clinical consequences associated with neural hyperactivity in conditions such as COPD and asthma.

Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, focused on enhancing respiratory rhythm management and cardiovascular health for heart failure patients. Founded in 2006, the company develops and manufactures innovative implantable stimulation therapy solutions, notably the remede System. This device is designed to restore normal breathing patterns during sleep for individuals suffering from central sleep apnea. Respicardia aims to improve the lives of these patients through safe and effective neurostimulation therapies that stimulate the phrenic nerve, thereby addressing critical needs in respiratory and cardiovascular health.

RedBrick Health is a health technology company based in Minneapolis, founded in 2006 to address the challenges posed by rising healthcare costs. The company offers an innovative approach that combines behavior-based health financing with personalized programs and independent advocacy. RedBrick Health's enterprise platform leverages advanced behavior design and data analytics to promote healthier behaviors and facilitate informed healthcare decisions among consumers. By partnering with employers, health plans, health systems, and accountable care organizations, RedBrick Health aims to enhance population health and well-being initiatives, ultimately delivering improved health outcomes and financial rewards for its clients.

Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, focused on enhancing respiratory rhythm management and cardiovascular health for heart failure patients. Founded in 2006, the company develops and manufactures innovative implantable stimulation therapy solutions, notably the remede System. This device is designed to restore normal breathing patterns during sleep for individuals suffering from central sleep apnea. Respicardia aims to improve the lives of these patients through safe and effective neurostimulation therapies that stimulate the phrenic nerve, thereby addressing critical needs in respiratory and cardiovascular health.

Hicuity Health is a technology-enabled clinical services provider specializing in high-acuity telehealth. It contracts to deliver care to more than 115 hospitals across 30 states on a 24/7/365 basis. The company combines remote patient monitoring, virtual care services, real-time clinical data integration, and access to specialized medical teams to support critical care delivery. It operates dedicated tele-care delivery centers and employs U.S. board-certified intensivists to support hospitals, families, and patients with improved oversight and care coordination, enabling scalable, around-the-clock critical care support for health systems.

RedBrick Health is a health technology company based in Minneapolis, founded in 2006 to address the challenges posed by rising healthcare costs. The company offers an innovative approach that combines behavior-based health financing with personalized programs and independent advocacy. RedBrick Health's enterprise platform leverages advanced behavior design and data analytics to promote healthier behaviors and facilitate informed healthcare decisions among consumers. By partnering with employers, health plans, health systems, and accountable care organizations, RedBrick Health aims to enhance population health and well-being initiatives, ultimately delivering improved health outcomes and financial rewards for its clients.